Cipla Ltd
NSE:CIPLA
Cipla Ltd
NSE:CIPLA
Price:
1 196.9
INR
-2.23%
Market Closed
Market Cap:
₹966.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cipla Ltd
NSE:CIPLA
|
IN |
|
Tritax Big Box Reit PLC
LSE:BBOX
|
UK |
|
Ampeak Energy Ltd
LSE:AMP
|
UK |
|
C
|
Centuria Industrial Reit
ASX:CIP
|
AU |
|
C
|
Cakra Buana Resources Energi PT Tbk
IDX:CBRE
|
ID |
|
Cake Box Holdings PLC
LSE:CBOX
|
UK |
|
Mullen Group Ltd
TSX:MTL
|
CA |
Multiples-Based Value
The
Multiples-Based Value for
Cipla Ltd (CIPLA)
under the Base Case is
hidden
INR.
Compared with the current market price of 1 196.9 INR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CIPLA Multiples-Based Value
LOCKED
Multiples Across Competitors
CIPLA Competitors Multiples
Cipla Ltd Competitors
Cipla Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Cipla Ltd
NSE:CIPLA
|
988.9B INR | 3.4 | 21.2 | 13.4 | 16.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 14.1 | 44.6 | 30.1 | 32.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.4 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.6 | 17.7 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
